The United Kingdom has become the first country to give regulatory approval to a medical treatment involving the revolutionary CRISPR gene editing tool.

In the never-ending quest to discover previously unknown CRISPR gene-editing systems, researchers have scoured microbes in everything from hot springs and peat bogs to poo and even yogurt. Now ...

CRISPR investors are looking for the big home-run hitters, while those with more modest scientific goals are, more often than not, the ones who deliver.

Discover how CRISPR gene editing is creating personalized cancer therapies, enhancing immunotherapy, and offering new hope for hard-to-treat cancers.

The decision comes after Vertex Pharmaceuticals and CRISPR Therapeutics’ Casgevy was approved in the UK and US for sickle cell disease and beta thalassemia.

Researchers turn to CRISPR to unlock one of the trickiest diseases to treat: Alzheimer's.

The gene-editing technique known as CRISPR is promising to revolutionize medicine. Some researchers are trying to help make it available for people with very rare genetic disorders.

Pioneering biochemist Jennifer Doudna sat down with WIRED’s Emily Mullin to talk about the future of Crispr.

No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation Program, which will allow innovators to have an easier path to market.

Vertex is severing one of its ties to CRISPR Therapeutics. The big biotech has chosen to opt out of the diabetes gene-edited stem cell therapy it gained through the acquisition of ViaCyte, leaving ...